SAN FRANCISCO – Wall Street isn't happy with oncology med-tech Novocure Ltd. The St. Helier, Jersey-based company is working to secure Medicaid reimbursement for its FDA-approved glioblastoma indication – and to move into other solid tumors – all while working to breakeven on its cash in hand. Read More
